MedTrace Logo

Clinical-immunological Features of Anti-NMDAR Encephalitis

NCT05738668 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-02-22

No results posted yet for this study

Summary

Using a retrospective cohort of 501 patients with anti-NMDAR encephalitis to assess clinical and immunological prognostic biomarkers

Conditions

  • Anti NMDA Receptor Encephalitis

Interventions

OTHER

Description of clinical characteristic

This is a non-interventional study involving clinical data and biological samples (blood, DNA, CSF). Clinical data are collected for the center and samples are already stored in biobank repositories and collected as part of "good clinical practice" in the diagnostic process of patients with suspected autoimmune encephalitis, meaning that the standard diagnostic and therapeutic approaches will not be altered in the selected study population. Patients have already gave explicit written consent for biological specimens sampling and storage at the "Centre de Ressources Biologiques des Hospices Civils de Lyon" (CRB-HCL) (including tissue, cells or biological fluids) and genetic analysis for research purposes. Additionally, patients will be informed about the present study.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-10-01
Completion
2025-02-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738668 on ClinicalTrials.gov